Literature DB >> 9890569

Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion.

Z Shutenko1, Y Henry, E Pinard, J Seylaz, P Potier, F Berthet, P Girard, R Sercombe.   

Abstract

We characterized the changes in nitric oxide (NO) levels in the brain during global forebrain ischemia and reperfusion and tested the ability of the natural flavonoid, quercetin, and a synthetic flavonoid, FB277, to increase the amount of available NO by elimination of the superoxide radicals produced during reperfusion. In Sprague-Dawley rats, we used a four-vessel occlusion model of forebrain ischemia (15 min) and reperfusion (30 min). Brain NO was measured on samples of cerebral cortex and cerebellum ex vivo by electron paramagnetic resonance (EPR) spectroscopy. The spin trap used was diethyldithiocarbamate sodium salt (DETC) associated with ferrous citrate. The complex Fe(DETC)2NO was detected at 77 K as a triplet signal at g = 2.035. Groups of animals were treated with quercetin or FB277 (3-morpholinomethyl-3',4',5,7tetramethoxyflavone) or polyethylene glycol-conjugated superoxide dismutase (PEG-SOD). In control (intact anesthetized animals), the signal was about 3 times greater in the cortex than in the cerebellum. During ischemia, the signal rose to 110% in cortex (NS) and 283% in cerebellum (P < 0.05). In reperfusion, it fell again to 91% of control in cerebellum (NS) and 35% in cortex (P < 0.05). Treatment by quercetin (5 mg/kg i.v.) of intact and ischemia-reperfusion groups did not significantly change the signal amplitude in the cerebellum, but did double it in the cortex (to 76% of control) for the ischemia-reperfusion group (P < 0.05). In contrast, FB277 (3.75 mg/kg i.v.) did not increase the signal in the cortex during ischemia-reperfusion, but did do so in the cerebellum (to 152% of control, P < 0.05). The results obtained for PEG-SOD (10,000 U/kg i.v.) were similar to those for FB277. In separate in vitro measurements, we found that quercetin but not FB277 efficiently scavenged superoxide. We hypothesize that quercetin but not FB277 scavenged superoxide anions released in the cortex during reperfusion, thus diminishing the amount of NO removed by the formation of peroxynitrite. The lack of effect of PEG-SOD may be related to the need for chronic treatment to obtain protection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890569     DOI: 10.1016/s0006-2952(98)00296-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  25 in total

1.  Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats.

Authors:  J Duarte; R Pérez-Palencia; F Vargas; M A Ocete; F Pérez-Vizcaino; A Zarzuelo; J Tamargo
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Therapeutic efficacy of Kalpaamruthaa on reactive oxygen/nitrogen species levels and antioxidative system in mammary carcinoma bearing rats.

Authors:  Krishnamurthi Veena; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2006-08-08       Impact factor: 3.396

Review 3.  Polyphenols in cerebral ischemia: novel targets for neuroprotection.

Authors:  Agnes Simonyi; Qun Wang; Rebecca L Miller; Mozow Yusof; Phullara B Shelat; Albert Y Sun; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

4.  Dietary soy may not confound acute experimental stroke infarct volume outcomes in ovariectomized female rats.

Authors:  Kamm D Prongay; Anne D Lewis; Patricia D Hurn; Stephanie J Murphy
Journal:  Lab Anim       Date:  2010-02-10       Impact factor: 2.471

5.  Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach.

Authors:  Fawad-Ali Shah; Dong-Ju Park; Phil-Ok Koh
Journal:  Neurochem Res       Date:  2018-06-20       Impact factor: 3.996

6.  Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats.

Authors:  J Duarte; M Galisteo; M A Ocete; F Pérez-Vizcaino; A Zarzuelo; J Tamargo
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

7.  The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction.

Authors:  Olivier Pétrault; Michèle Bastide; Nicole Cotelle; Patrick Gelé; Sophie Gautier; Maud Laprais; Joseph Vamecq; Patrick Duriez; Régis Bordet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-19       Impact factor: 3.000

Review 8.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.

Authors:  Ana García-Lafuente; Eva Guillamón; Ana Villares; Mauricio A Rostagno; José Alfredo Martínez
Journal:  Inflamm Res       Date:  2009-04-21       Impact factor: 4.575

9.  Cell culture protection and in vivo neuroprotective capacity of flavonoids.

Authors:  Federico Dajas; Felicia Rivera; Fernanda Blasina; Florencia Arredondo; Carolina Echeverry; Laura Lafon; Andrea Morquio; Horacio Heinzen; Horacio Heizen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 10.  Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.